ECE2020 ePoster Presentations Hot topics (including COVID-19) (57 abstracts)
1Tashkent Pediatric Medical Institute, endocrinology, Tashkent, Uzbekistan; 2Republican Specialized Scientific Practical Medical Center of Endocrinology of Public Health Ministry named by acad. Ya.Kh. Turakulov, hemodialysis, Tashkent, Uzbekistan
The aim of investigation: To study clinical characteristics of patients with type 1 and type 2 diabetes who received hemodialysis in 2017 year
Material and research methods: We for the period from January, 01.2017 to December, 31, 2017 year 102 patients with type 1 and type 2 diabetes mellitus were examined. Of these, men – 45 (44.1%), women – 57 (55.9%). Average age: men amounted to 57.12 years, women – 58.15 years. 20 of them were urgently received hemodialysis. The research methods included: 1) general clinical (study of endocrine, neurological status, anthropometry 2) instrumental (fundus, visual acuity, ECG, densitometry, Ultrasound of internal organs and dopplerography of the main arteries of the head, etc.), 3) biochemical tests (Hb1AC, glycemic profile, urea, creatinine, lipid spectrum, coagulogram),4) hormonal blood tests (insulin, C-peptide etc.)
Research results: Depending on the degree of diabetic encephalopathy, all observed patients were divided into 3 groups:1 gr – 23 patients with diabetic nephropathy of 4–5 stages with CBI 1 st (chronic brain ischemia); 2 gr. – 45 patients with diabetic nephropathy of 4–5 stages with CBI 2 st; 3 gr. – 34 patients with diabetic nephropathy of stages 4–5 with CBI 3 st. Analysis of clinical and medical history studies showed that the duration of the disease prevailed in patients of the 3rd group – 22.5 years, while in patients of the 2nd group – 15.6 years, and in patients of the 1st group – 11.7 years. 22 patients were died during year. Stage 5 diabetic nephropathy was detected in all patients
Conclusions: 1) Among the examined 102 patients, patients with a 2 degree of chronic cerebral ischemia prevailed; 2) The duration of the disease prevailed in patients of the 3rd group – 22.5 years